@InProceedings{BOOK1,
	author=	{Frederic H. Martini, Robert B. Tallitsch, Judi L. Nath},
	title=	{{Anatomia umana}},
	booktitle=	{{Anatomia umana }},
	year=	{2019},
}

@InProceedings{BOOK2,
	author=	{Luciano Zocchi},
	title=	{{Principi di fisiologia}},
	booktitle=	{{Principi di fisiologia}},
	year=	{2012},
}

@misc{LINFOMIAIL,
	author = {AIL},
	title = {{Linfomi AIL}},
	url = {{https://www.ail.it/patologie-e-terapie/patologie-ematologiche/linfomi}},
}

@misc{img1,
	author = { },
	title = {{https://www.pharmacy180.com/article/lymphatic-system-and-immunity-3637/}},
	url = {{https://www.pharmacy180.com/article/lymphatic-system-and-immunity-3637/}},
}

@misc{img2,
	author = { },
	title = {{https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymph-system}},
	url = {{https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymph-system}},
}

@misc{LNHAIL,
	author = {AIL },
	title = {{LNH AIL}},
	url = {{https://www.ail.it/patologie-e-terapie/patologie-ematologiche/linfomi/576-linfoma-non-hodgkin}},
}

@misc{LNHAIMAC,
	author = {AIMAC },
	title = {{AIMAC}},
	url = {{https://www.aimac.it/libretti-tumore/linfomi-non-hodgkin/qual-e-la-differenza-tra-linfoma-di-hodgkin-e-linfomi-non-hodgkin#:~:text=Un%20linfoma%20non%20Hodgkin%20si,dei%20linfomi%20del%20secondo%20tipo}},
}

@misc{AMERICANCS,
	author = {The American Cancer Society medical and editorial content team},
	title = {{Non-Hodgkin Lymphoma Causes, Risk
Factors, and Prevention}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8718.00.pdf}},
}

@misc{AIOM,
	author = {AIOM Associazione Italiana di Oncologia Medica},
	title = {{Linee guida linfomi}},
	url = {{https://www.aiom.it/wp-content/uploads/2018/11/2018_LG_AIOM_Linfomi.pdf}},
}

@misc{AIRTUM,
	author = {Associazione Italiana Registri Tumori},
	title = {{Cos'è AIRTUM}},
	url = {{https://www.registri-tumori.it/cms/pagine/cosa-%C3%A9-airtum}},
}

@misc{AIRC,
	author = {AIRC Associazione Italiana Ricerca Cancro},
	title = {{Guida ai tumori. Linfoma non-Hodgkin}},
	url = {{https://www.airc.it/cancro/informazioni-tumori/guida-ai-tumori/linfoma-non-hodgkin}},
}

@misc{Americanstatistic,
	author = {American Statistic Center},
	title = {{Linfoma non-Hodgkin 2022 Estimates}},
	url = {{https://cancerstatisticscenter.cancer.org/#!/}}
}

@misc{reteveneta,
	author = {Rete Ematologica Veneta},
	title = {{Percorsi Diagnostico Terapeutici Assistenziali (PDTA)
LINFOMI NON HODGKIN}},
	url = {{https://rev.aopd.veneto.it/all/PDTA_Linfomi_Non_Hodgkin.pdf}}
}

@misc{LLS,
	author = {Leukemia and Lymphoma Society},
	title = {{Non-Hodgkin Lymphoma}},
	url = {{https://www.lls.org/sites/default/files/2022-07/PS58_NHL_2022.pdf}}
}

@misc{ISTGENT,
	author = {Gentili Oncology},
	title = {{Linfoma Non Hodgkin}},
	url = {{https://www.istitutogentili.com/it/oncologia/linfomi/linfoma-non-hodgkin/#:~:text=L'Indice%20Prognostico%20Internazionale%20(IPI,svolgere%20le%20attivit%C3%A0%20quotidiane)%20e}}
}

@InProceedings{MIPI,
	author=	{Lim SY,Horsman JM,Hancock BW.},
	title=	{{The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?}},
	booktitle=	{{Oncol Lett.}},
	month=	{Jan},
	year=	{2010},
}

@misc{img3,
	author = { },
	title = {{https://www.ail.it/patologie-e-terapie/patologie-ematologiche/linfomi/576-linfoma-non-hodgkin}},
	url = {{https://www.ail.it/patologie-e-terapie/patologie-ematologiche/linfomi/576-linfoma-non-hodgkin}},
}

@misc{AMERICANCANCER,
	author = {American Cancer Society},
	title = {{Non-Hodgkin Lymphoma Early
Detection, Diagnosis, and Staging}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8719.00.pdf}}
}

@misc{ISS,
	author = {Istituto Superiore di Sanità},
	title = {{Linfoma non Hodgkin (LNH)}},
	url = {{https://www.issalute.it/index.php/la-salute-dalla-a-alla-z-menu/l/linfoma-non-hodgkin#diagnosi}}
}

@misc{img4,
	author = { },
	title = {{hshorturl.at/ilnV5}},
	url = {{shorturl.at/ilnV5}},
}

@misc{img5,
	author = { },
	title = {{shorturl.at/qsuWY}},
	url = {{shorturl.at/qsuWY}},
}

@misc{img6,
	author = { },
	title = {{shorturl.at/FGVY1}},
	url = {{shorturl.at/FGVY1}},
}

@misc{img7,
	author = { },
	title = {{shorturl.at/FGVY1}},
	url = {{shorturl.at/FGVY1}},
}

@misc{img8,
	author = { },
	title = {{shorturl.at/ipq19}},
	url = {{shorturl.at/ipq19}},
}

@misc{img9,
	author = { },
	title = {{shorturl.at/ipq19}},
	url = {{shorturl.at/ipq19}},
}

@misc{img10,
	author = { },
	title = {{shorturl.at/ipq19}},
	url = {{shorturl.at/ipq19}},
}

@misc{img11,
	author = { },
	title = {{shorturl.at/ipq19}},
	url = {{shorturl.at/ipq19}},
}

@misc{img12,
	author = { },
	title = {{shorturl.at/ipq19}},
	url = {{shorturl.at/ipq19}},
}

@misc{img13,
	author = { },
	title = {{shorturl.at/ipq19}},
	url = {{shorturl.at/ipq19}},
}

@misc{img14,
	author = { },
	title = {{shorturl.at/ipq19}},
	url = {{shorturl.at/ipq19}},
}

@misc{img15,
	author = { },
	title = {{https://www.ematologiainprogress.it/linfoma-non-hodgkin/}},
	url = {{https://www.ematologiainprogress.it/linfoma-non-hodgkin/}},
}

@misc{img16,
	author = { },
	title = {{https://www.lls.org/lymphoma/non-hodgkin-lymphoma/diagnosis/nhl-staging}},
	url = {{https://www.lls.org/lymphoma/non-hodgkin-lymphoma/diagnosis/nhl-staging}},
}

@misc{img17,
	author = { },
	title = {{shorturl.at/BENX3}},
	url = {{shorturl.at/BENX3}},
}

@misc{img18,
	author = { },
	title = {{https://www.ematologiainprogress.it/linfoma-non-hodgkin/}},
	url = {{https://www.ematologiainprogress.it/linfoma-non-hodgkin/}},
}

@misc{img19,
	author = { },
	title = {{https://www.infomedics.it/therapeutic-areas/leucemie-e-linfomi/lnh/linfoma-follicolare/indici-prognostici-linfoma-follicolare.html}},
	url = {{https://www.infomedics.it/therapeutic-areas/leucemie-e-linfomi/lnh/linfoma-follicolare/indici-prognostici-linfoma-follicolare.html}},
}

@misc{img20,
	author = { },
	title = {{shorturl.at/dtxH1}},
	url = {{shorturl.at/dtxH1}},
}

@misc{img21,
	author = { },
	title = {{shorturl.at/BENX3}},
	url = {{shorturl.at/BENX3}},
}

@misc{NIH,
	author = {National Cancer Institute},
	title = {{Radiation Therapy to Treat Cancer}},
	url = {{https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy}}
}

@misc{ACSRADIATION,
	author = {American Cancer Society},
	title = {{Treating Non-Hodgkin Lymphoma}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8720.00.pdf}}
}

@misc{MACMILLAN,
	author = {Macmillan Cancer Support},
	title = {{Radiotherapy}},
	url = {{https://www.macmillan.org.uk/cancer-information-and-support/treatment/types-of-treatment/radiotherapy}}
}

@misc{UKRADIOTP,
	author = {Cancer Research UK},
	title = {{Radiotherapy treatment}},
	url = {{https://www.cancerresearchuk.org/about-cancer/non-hodgkin-lymphoma/treatment/radiotherapy/treatment}}
}

@misc{IMMUNOTP,
	author = {American Cancer Society},
	title = {{Immunotherapy}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/6678.00.pdf}}
}

@misc{LLSIMMUNO,
	author = {Leukemia and Lymphoma Society},
	title = {{Immunotherapy}},
	url = {{https://www.lls.org/sites/default/files/2021-05/FS9_Immunotherapy_Facts2020FINAL.pdf}}
}

@misc{NIHCART,
	author = {National Cancer Institute},
	title = {{CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers}},
	url = {{https://www.cancer.gov/about-cancer/treatment/research/car-t-cells}}
}

@misc{img22,
	author = { },
	title = {{https://www.cancer.gov/about-cancer/treatment/research/car-t-cells}},
	url = {{https://www.cancer.gov/about-cancer/treatment/research/car-t-cells}},
}

@misc{EMATOCART,
	author = {Ematologia In Progress},
	title = {{Cellule CAR-T}},
	url = {{https://www.ematologiainprogress.it/cellule-car-t/}}
}

@misc{LLSCART,
	author = {Leukemia and Lymphoma Society},
	title = {{Chimeric Antigen Receptor (CAR) T-Cell Therapy}},
	url = {{https://www.lls.org/sites/default/files/2022-07/FS27_CART_rev_7_22.pdf}}
}

@misc{AILCENTRI,
	author = {Associazione Italiana contro Leucemie Linfomi e Mielomi},
	title = {{I centri autorizzati alla somministrazione delle terapie CAR-T}},
	url = {{https://www.ail.it/patologie-e-terapie/terapie/car-t/l-accesso-alle-car-t/centri-autorizzati}}
}

@misc{img23,
	author = { },
	title = {{https://www.ematologiainprogress.it/cellule-car-t/}},
	url = {{https://www.ematologiainprogress.it/cellule-car-t/}},
}

@misc{img24,
	author = { },
	title = {{https://m.teamintraining.org/treatment/types-of-treatment/immunotherapy/chimeric-antigen-receptor-car-t-cell-therapy}},
	url = {{https://m.teamintraining.org/treatment/types-of-treatment/immunotherapy/chimeric-antigen-receptor-car-t-cell-therapy}},
}


@InProceedings{Frontiers,
	author=	{Miao L, Zhang Z, Ren Z and
Li Y},
	title=	{{ Reactions Related
to CAR-T Cell Therapy}},
	booktitle=	{{ Front Immunol}},
	month=	{April},
	year=	{2021},
}

@misc{img25,
	author = { },
	title = {{https://www.ematologiainprogress.it/cellule-car-t/}},
	url = {{https://www.ematologiainprogress.it/cellule-car-t/}},
}

@InProceedings{Cortico,
  author =  {Liu S,Deng B,Yin Z et al.},
  title =  {{ Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia}},
  booktitle =  {{ Blood cancer journal}},
  month =  {Feb},
  year =  {2020},
}

@InProceedings{ASTCT,
	author=	{Lee DW,Santomasso BD,Locke FL et al.},
	title=	{{ ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells}},
	booktitle=	{{ Biol Blood Marrow Transplant}},
	month=	{April},
	year=	{2019},
}

@misc{img26,
	author = { },
	title = {{https://www.ematologiainprogress.it/wp-content/uploads/2020/08/Tabella-II.jpg}},
	url = {{https://www.ematologiainprogress.it/wp-content/uploads/2020/08/Tabella-II.jpg}},
}

@misc{img27,
	author = { },
	title = {{https://www.ematologiainprogress.it/cellule-car-t/}},
	url = {{https://www.ematologiainprogress.it/cellule-car-t/}},
}

@misc{MASSIVEBIO,
	author = {Massive Bio},
	title = {{Immunotherapy for Non-Hodgkin Lymphoma}},
	url = {{https://massivebio.com/immunotherapy-for-lymphoma/}}
}

@misc{LOWGRADE,
	author = {Lymphoma Action},
	title = {{Low-grade non-Hodgkin lymphoma}},
	url = {{shorturl.at/astz2}}
}

@InProceedings{BORTEZOMIB,
	author=	{Kurtin S,Knop CS,Milliron T},
	title=	{{ Subcutaneous administration of bortezomib: strategies to reduce injection site reactions.}},
	booktitle=	{{ J Adv Pract Oncol.}},
	month=	{November},
	year=	{2012},
}

@misc{BORTNURSES,
	author = {Myeloma Special Practice Network(M-SPN)},
	title = {{BORTEZOMIB
BEST PRACTICE
A guide for nurses}},
	url = {{shorturl.at/uPT79}}
}

@misc{img28,
	author = { },
	title = {{shorturl.at/djtxT}},
	url = {{shorturl.at/djtxT}},
}

@misc{img29,
	author = { },
	title = {{https://www.semanticscholar.org/paper/Subcutaneous-Administration-of-Bortezomib:-to-Site-Kurtin-Knop/553030bd100e9d8cca67fb7aaa875ca7f4df665e/figure/3}},
	url = {{https://www.semanticscholar.org/paper/Subcutaneous-Administration-of-Bortezomib:-to-Site-Kurtin-Knop/553030bd100e9d8cca67fb7aaa875ca7f4df665e/figure/3}},
}

@misc{img30,
	author = { },
	title = {{https://www.semanticscholar.org/paper/Subcutaneous-Administration-of-Bortezomib:-to-Site-Kurtin-Knop/553030bd100e9d8cca67fb7aaa875ca7f4df665e}},
	url = {{https://www.semanticscholar.org/paper/Subcutaneous-Administration-of-Bortezomib:-to-Site-Kurtin-Knop/553030bd100e9d8cca67fb7aaa875ca7f4df665e}},
}

@misc{img31,
	author = { },
	title = {{shorturl.at/uPT79}},
	url = {{shorturl.at/uPT79}},
}

@misc{img32,
	author = { },
	title = {{shorturl.at/uPT79}},
	url = {{shorturl.at/uPT79}},
}

@misc{img33,
	author = { },
	title = {{shorturl.at/uPT79}},
	url = {{shorturl.at/uPT79}},
}

@misc{img34,
	author = { },
	title = {{shorturl.at/uPT79}},
	url = {{shorturl.at/uPT79}},
}

@misc{TRAPIANTO,
	author = {Unità Operativa e Centro Trapianti di Midollo
Osseo “Wilma Deplano”.
Ospedale Oncologico “Armando Businco”
Cagliari},
	title = {{IL TRAPIANTO DI MIDOLLO OSSEO
O DI CELLULE STAMINALI
EMOPOIETICHE PERIFERICHE
Guida informativa per i pazienti}},
	url = {{shorturl.at/bdMU0}}
}

@misc{STEMCELLS,
	author = {American Cancer Society},
	title = {{Stem Cell or Bone Marrow Transplant}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/128.00.pdf}}
}

@misc{LLSBLOOD,
	author = {Leukemia and Lymphoma Society},
	title = {{Blood and Marrow
Stem Cell
Transplantation
Guide}},
	url = {{shorturl.at/jACUZ}}
}

@misc{img35,
	author = { },
	title = {{https://filinf.it/en/about-limphomas/transplantation/}},
	url = {{https://filinf.it/en/about-limphomas/transplantation/}},
}

@InProceedings{TRANS,
	author=	{Li C,Zhang Y,Zhang C et al.},
	title=	{{ Comparation of CART19 and autologous stem-cell transplantation for refractory/relapsed non-Hodgkin's lymphoma.}},
	booktitle=	{{ JCI Insight.}},
	month=	{July},
	year=	{2019},
}

@misc{img36,
	author = { },
	title = {{https://www.lls.org/treatment/types-treatment/stem-cell-transplantation/autologous-stem-cell-transplantation}},
	url = {{https://www.lls.org/treatment/types-treatment/stem-cell-transplantation/autologous-stem-cell-transplantation}},
}

@misc{img37,
	author = { },
	title = {{https://www.lls.org/treatment/types-treatment/stem-cell-transplantation/autologous-stem-cell-transplantation}},
	url = {{https://www.lls.org/treatment/types-treatment/stem-cell-transplantation/autologous-stem-cell-transplantation}},
}

@InProceedings{GVHD,
	author=	{Martin PJ,Rizzo JD,Wingard JR et al.},
	title=	{{ First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.}},
	booktitle=	{{ Biol Blood Marrow Transplant.}},
	month=	{April},
	year=	{2012},
}

@misc{img38,
	author = { },
	title = {{https://bethematch.org/patients-and-families/life-after-transplant/physical-health-and-recovery/gvhd-signs-and-symptoms/}},
	url = {{https://bethematch.org/patients-and-families/life-after-transplant/physical-health-and-recovery/gvhd-signs-and-symptoms/}},
}

@misc{CHEMOUK,
	author = {Cancer Research UK},
	title = {{Chemotherapy treatment}},
	url = {{https://www.cancerresearchuk.org/about-cancer/non-hodgkin-lymphoma/treatment/chemotherapy/about}}
}

@misc{CHEMOAMERICAN,
	author = {American Cancer Society},
	title = {{How Is Chemotherapy Used to Treat
Cancer?}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8417.00.pdf}}
}

@misc{LYMPHACTION,
	author = {Lymphoma Action},
	title = {{Chemotherapy}},
	url = {{shorturl.at/evTXY}}
}

@misc{CNS,
	author = {Lymphoma Action},
	title = {{CNS prophylaxis}},
	url = {{shorturl.at/bfJ79}}
}

@misc{img39,
	author = { },
	title = {{Lumbar Puncture (Spinal tap)}},
	url = {{https://curesearch.org/Lumbar-Puncture}},
}

@misc{HIGHGRADE,
	author = {Lymphoma Action},
	title = {{High-grade
non-Hodgkin
lymphoma}},
	url = {{shorturl.at/lO069}}
}

@misc{AIOMTOSS,
	author = {AIOM Associazione Italiana di Oncologia Medica},
	title = {Linee guida GESTIONE DELLA TOSSICIT\'A EMATOPOIETICA IN ONCOLOGIA}},
	url = {{shorturl.at/BENW8}}
}

@misc{LLSLOWCELLS,
	author = {LEUKEMIA AND LYMPHOMA SOCIETY},
	title = {SIDE-EFFECT MANAGEMENT: Managing Low Blood Cell Counts}},
	url = {{shorturl.at/glILV}}
}

@misc{AMERICANLOWCELLS,
	author = {American Cancer Society},
	title = {Low Red Blood Cell Counts (Anemia)}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/7529.pdf}}
}

@misc{AMERICANPLATELET,
	author = {American Cancer Society},
	title = {Low Platelet Count (Bleeding)}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8900.00.pdf}}
}

@misc{AMERICANFERTILITY,
	author = {American Cancer Society},
	title = {How Cancer And Cancer Treatment Can
Affect Fertility}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/9255.00.pdf}}
}

@misc{UKFERTILITY,
	author = {Cancer Research UK},
	title = {Sex and fertility}},
	url = {{https://www.cancerresearchuk.org/about-cancer/non-hodgkin-lymphoma/living-with/sex-fertility}}
}

@misc{ISSESPO,
	author = {ISTITUTO SUPERIORE DI SANITÀ},
	title = {Esposizione professionale
a chemioterapici antiblastici:
rischi per la riproduzione
e strategie per la prevenzione}},
	url = {{shorturl.at/beKLP}}
}

@misc{FNOPI,
	author = {MINISTERO DELLA SANITÀ DIPARTIMENTO DELLA PREVENZIONE COMMISSIONE ONCOLOGICA NAZIONALE},
	title = {Linee guida per la sicurezza e la salute dei lavoratori esposti a chemioterapici antiblastici in ambiente sanitario}},
	url = {{https://www.fnopi.it/wp-content/uploads/PROV050899.pdf}}
}

@misc{GAVECELTCVC,
	author = {GAVeCeLT Gli Accessi Venosi Centrali a Lungo Termine},
	title = {Cateteri	Midline	vs.	altri	accessi	
venosi	periferici	nella	terapia	
endovenosa	}},
	url = {{https://gavecelt.it/nuovo/sites/default/files/uploads/Gli-accessi-venosi-periferici-oggi.pdf}}
}

@misc{GAVECELTracc2021,
	author = {GAVeCeLT Gli Accessi Venosi Centrali a Lungo Termine},
	title = {RACCOMANDAZIONI GAVeCeLT 2021
PER LA INDICAZIONE, L’IMPIANTO E LA GESTIONE
DEI DISPOSITIVI PER ACCESSO VENOSO}},
	url = {{shorturl.at/nopBP}}
}

@misc{img40,
	author = { },
	title = {{https://www.ospedalimarchenord.it/percorsi-di-cura/posizionamento-picc-e-midline/}},
	url = {{https://www.ospedalimarchenord.it/percorsi-di-cura/posizionamento-picc-e-midline/}},
}

@misc{img41,
	author = { },
	title = {{shorturl.at/lwyZ9}},
	url = {{shorturl.at/lwyZ9}},
}

@misc{img42,
	author = { },
	title = {{https://www.cancer.gov/publications/dictionaries/cancer-terms/def/port-a-cath}},
	url = {{https://www.cancer.gov/publications/dictionaries/cancer-terms/def/port-a-cath}},
}

@misc{AIOMCVC,
	author = {AIOM Associazione Italiana di Oncologia Medica},
	title = {Working Group Nursing
Gestione infermieristica
degli accessi vascolari centrali a medio e lungo termine
nel paziente oncologico}},
	url = {{shorturl.at/jvMU5}}
}

@misc{img43,
	author = { },
	title = {{https://infermieriattivi.it/tecniche-e-tecnologie/1862-port-a-cath-flush-con-ago-di-huber-verso.html}},
	url = {{https://infermieriattivi.it/tecniche-e-tecnologie/1862-port-a-cath-flush-con-ago-di-huber-verso.html}},
}

@misc{img44,
	author = { },
	title = {{https://www.officiumroma.it/wp-content/uploads/2017/09/tre-ante-porth.pdf}},
	url = {{https://www.officiumroma.it/wp-content/uploads/2017/09/tre-ante-porth.pdf}},
}

@misc{img45,
	author = { },
	title = {{shorturl.at/tDHJ8}},
	url = {{shorturl.at/tDHJ8}},
}

@misc{img46,
	author = { },
	title = {{https://nursetimes.org/cateteri-venosi-centrali-e-sistema-needle-free-connectors-nfc-pills/55254}},
	url = {{https://nursetimes.org/cateteri-venosi-centrali-e-sistema-needle-free-connectors-nfc-pills/55254}},
}

@misc{img47,
	author = { },
	title = {{shorturl.at/qAST1}},
	url = {{shorturl.at/qAST1}},
}

@misc{CRO,
	author = {CRO Centro di Riferimento Oncologico di Aviano},
	title = {Il PICC-PORT
Guida per il paziente}},
	url = {{https://www.cro.it/export/sites/cro/it/biblioteca/croinforma/pubblicazioni/PICC-PORTpazienti.pdf}}
}

@misc{GAVECELTPICCPORT,
	author = {GAVeCeLT Gli Accessi Venosi Centrali a Lungo Termine},
	title = {Il ruolo futuro dei Picc-Port
in Oncologia}},
	url = {{shorturl.at/FMPTW}}
}

@InProceedings{MERLICCO,
	author=	{Merlicco D, Lombardi M, Fino MC.},
	title=	{{ PICC-PORT: Valid indication to placement in patient with results of extensive skin burns of the neck and chest in oncology. The first case in the scientific literature.}},
	booktitle=	{{ Int J Surg Case Rep.}},
	month=	{February},
	year=	{2020},
}